Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective.

López-Méndez, Tania B; Sánchez-Álvarez, Miguel; Trionfetti, Flavia; Pedraz, José L; Tripodi, Marco; Cordani, Marco; Strippoli, Raffaele; González-Valdivieso, Juan

López-Méndez, Tania B; Sánchez-Álvarez, Miguel; Trionfetti, Flavia; Pedraz, José L; Tripodi, Marco; Cordani, Marco; Strippoli, Raffaele; González-Valdivieso, Juan.

Afiliação

López-Méndez TB; NanoBioCel Group, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain.
Sánchez-Álvarez M; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain.
Trionfetti F; Area of Cell and Developmental Biology. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Pedraz JL; Instituto de Investigaciones Biomédicas Alberto Sols (IIB), Madrid, Spain.
Tripodi M; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Cordani M; National Institute for Infectious Diseases L. Spallanzani IRCCS, Rome, Italy.
Strippoli R; NanoBioCel Group, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain.
González-Valdivieso J; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain.

Cell Biosci ; 13(1): 44, 2023 Mar 04.

Article em En | MEDLINE | ID: mdl-36871010

Palavras-chave

Autophagy; Biomaterials; Cancer; Clinical trials; Nanomedicine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cell Biosci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google